Genfit SA (GNFT)
3.70
+0.04
(+1.09%)
USD |
NASDAQ |
May 06, 16:00
3.70
0.00 (0.00%)
After-Hours: 20:00
Genfit Max Drawdown (5Y): 88.42% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 88.42% |
| March 31, 2024 | 88.42% |
| February 29, 2024 | 88.42% |
| January 31, 2024 | 88.42% |
| December 31, 2023 | 88.42% |
| November 30, 2023 | 88.42% |
| October 31, 2023 | 88.42% |
| September 30, 2023 | 88.27% |
| August 31, 2023 | 88.27% |
| July 31, 2023 | 88.27% |
| June 30, 2023 | 88.27% |
| May 31, 2023 | 88.27% |
| April 30, 2023 | 88.27% |
| March 31, 2023 | 88.27% |
| February 28, 2023 | 88.27% |
| January 31, 2023 | 88.27% |
| December 31, 2022 | 88.27% |
| November 30, 2022 | 88.27% |
| October 31, 2022 | 88.27% |
| September 30, 2022 | 88.27% |
| August 31, 2022 | 88.27% |
| July 31, 2022 | 88.27% |
| June 30, 2022 | 88.27% |
| May 31, 2022 | 88.27% |
| April 30, 2022 | 88.27% |
| Date | Value |
|---|---|
| March 31, 2022 | 88.27% |
| February 28, 2022 | 88.27% |
| January 31, 2022 | 88.27% |
| December 31, 2021 | 88.27% |
| November 30, 2021 | 87.52% |
| October 31, 2021 | 86.55% |
| September 30, 2021 | 86.04% |
| August 31, 2021 | 86.04% |
| July 31, 2021 | 86.04% |
| June 30, 2021 | 85.85% |
| May 31, 2021 | 85.85% |
| April 30, 2021 | 85.85% |
| March 31, 2021 | 85.85% |
| February 28, 2021 | 85.85% |
| January 31, 2021 | 85.85% |
| December 31, 2020 | 85.85% |
| November 30, 2020 | 85.85% |
| October 31, 2020 | 85.85% |
| September 30, 2020 | 85.69% |
| August 31, 2020 | 81.33% |
| July 31, 2020 | 81.33% |
| June 30, 2020 | 79.73% |
| May 31, 2020 | 79.65% |
| April 30, 2020 | 57.31% |
| March 31, 2020 | 57.31% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
12.40%
Minimum
May 2019
88.42%
Maximum
Oct 2023
77.91%
Average
87.04%
Median
Max Drawdown (5Y) Benchmarks
| Biophytis SA | -- |
| Cellectis SA | 97.08% |
| DBV Technologies SA | 97.67% |
| Edap TMS SA | 70.31% |
| Adaptimmune Therapeutics PLC | 96.57% |